SE0101093D0 - Novel compound for treatment of allergy and asthma - Google Patents
Novel compound for treatment of allergy and asthmaInfo
- Publication number
- SE0101093D0 SE0101093D0 SE0101093A SE0101093A SE0101093D0 SE 0101093 D0 SE0101093 D0 SE 0101093D0 SE 0101093 A SE0101093 A SE 0101093A SE 0101093 A SE0101093 A SE 0101093A SE 0101093 D0 SE0101093 D0 SE 0101093D0
- Authority
- SE
- Sweden
- Prior art keywords
- allergy
- asthma
- treatment
- novel compound
- ige
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101093A SE0101093D0 (sv) | 2001-03-28 | 2001-03-28 | Novel compound for treatment of allergy and asthma |
PCT/SE2002/000636 WO2002079257A1 (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
CA2441048A CA2441048C (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
EP02720698A EP1373322A1 (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
US10/108,301 US6986889B2 (en) | 2001-03-28 | 2002-03-28 | Compound for treatment of allergy and asthma |
JP2002577880A JP2005500992A (ja) | 2001-03-28 | 2002-03-28 | アレルギーおよび喘息の治療用新規化合物 |
AU2002251624A AU2002251624B8 (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
US12/757,821 USRE42324E1 (en) | 2001-03-28 | 2010-04-09 | Compound for treatment of allergy and asthma |
JP2013166370A JP2014012683A (ja) | 2001-03-28 | 2013-08-09 | アレルギーおよび喘息の治療用新規化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101093A SE0101093D0 (sv) | 2001-03-28 | 2001-03-28 | Novel compound for treatment of allergy and asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0101093D0 true SE0101093D0 (sv) | 2001-03-28 |
Family
ID=20283563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0101093A SE0101093D0 (sv) | 2001-03-28 | 2001-03-28 | Novel compound for treatment of allergy and asthma |
Country Status (7)
Country | Link |
---|---|
US (2) | US6986889B2 (sv) |
EP (1) | EP1373322A1 (sv) |
JP (2) | JP2005500992A (sv) |
AU (1) | AU2002251624B8 (sv) |
CA (1) | CA2441048C (sv) |
SE (1) | SE0101093D0 (sv) |
WO (1) | WO2002079257A1 (sv) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6884877B2 (en) | 2001-10-03 | 2005-04-26 | Florida State University Research Foundation, Inc. | Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods |
WO2007041171A2 (en) | 2005-09-29 | 2007-04-12 | Medimmune, Inc. | Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells |
US10196458B2 (en) | 2013-07-26 | 2019-02-05 | The Regents Of The University Of California | Anti-immunoglobulin E antibodies and methods of using thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449760A (en) * | 1987-12-31 | 1995-09-12 | Tanox Biosystems, Inc. | Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
JP3156237B2 (ja) * | 1991-12-24 | 2001-04-16 | 雪印乳業株式会社 | 抗ヒトIgE モノクローナル抗体 |
US6037453A (en) * | 1995-03-15 | 2000-03-14 | Genentech, Inc. | Immunoglobulin variants |
GB9908533D0 (en) | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
AU5020700A (en) | 1999-05-26 | 2000-12-18 | Tanox, Inc. | Treating allergic diseases with immunotherapy and ige antagonists |
-
2001
- 2001-03-28 SE SE0101093A patent/SE0101093D0/sv unknown
-
2002
- 2002-03-28 CA CA2441048A patent/CA2441048C/en not_active Expired - Lifetime
- 2002-03-28 JP JP2002577880A patent/JP2005500992A/ja active Pending
- 2002-03-28 WO PCT/SE2002/000636 patent/WO2002079257A1/en active Application Filing
- 2002-03-28 AU AU2002251624A patent/AU2002251624B8/en not_active Expired
- 2002-03-28 EP EP02720698A patent/EP1373322A1/en not_active Ceased
- 2002-03-28 US US10/108,301 patent/US6986889B2/en not_active Ceased
-
2010
- 2010-04-09 US US12/757,821 patent/USRE42324E1/en not_active Expired - Lifetime
-
2013
- 2013-08-09 JP JP2013166370A patent/JP2014012683A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2002079257A1 (en) | 2002-10-10 |
US6986889B2 (en) | 2006-01-17 |
US20030035796A1 (en) | 2003-02-20 |
JP2014012683A (ja) | 2014-01-23 |
EP1373322A1 (en) | 2004-01-02 |
CA2441048A1 (en) | 2002-10-10 |
USRE42324E1 (en) | 2011-05-03 |
JP2005500992A (ja) | 2005-01-13 |
AU2002251624B2 (en) | 2008-09-04 |
CA2441048C (en) | 2011-12-13 |
AU2002251624B8 (en) | 2008-10-02 |
AU2002251624A2 (en) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0401601D0 (sv) | Protofibril specific antibodies and uses thereof | |
EA200400586A1 (ru) | Замещённые тиоацетамиды | |
MXPA00011422A (es) | Derivados de bencimidazol como moduladores de ige. | |
EE200700052A (et) | Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu | |
ATE504315T1 (de) | Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen | |
EA200201046A1 (ru) | 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное | |
NO20030845D0 (no) | Utvalgte fusjonerte pyrrolokarbazoler | |
AP1744A (en) | Inhibitors of factor XA and other serine proteases involved in the coagulation cascade | |
EA200300873A1 (ru) | Новая соль сукцинат o-десметилвенлафаксина | |
ATE307592T1 (de) | Epiallopregnanolon zur behandlung von krankheiten des cns | |
DE60215000D1 (de) | DIHYDROPYRROLOi1,2-AöINDOL- UND TETRAHYDROPYRIDOi1,2-AöINDOLDERIVATE ALS PROSTAGLANDIN REZEPTOR ANTAGONISTEN | |
AT500379B1 (de) | Tau-proteine | |
DE69433663D1 (de) | Antikörper gegen menschliches prostatspezifisches drüsenkallikrein | |
HUP0401614A2 (hu) | PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE373016T1 (de) | Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers | |
NO20033220D0 (no) | Inhibitorer for cruzipain og andre cysteinproteaser | |
ATE312096T1 (de) | Neue verbindungen | |
EP1610678A4 (en) | ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME USEFUL FOR INHIBITING METALLOPROTEIN ACTIVITY | |
EA200401081A1 (ru) | Fab-фрагменты моноклонального антитела человека, направленные против гликопротеина e2 hcv и обладающие нейтрализующей активностью in vitro | |
WO2003048207A3 (en) | Anti-dota antibody | |
DE50208918D1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
HN2002000366A (es) | Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma | |
SE0101093D0 (sv) | Novel compound for treatment of allergy and asthma | |
HRP20031057B1 (hr) | Tableta koja sadrži cetirizin i pseudoefedrin | |
ATE370160T1 (de) | Peptide mit affinität zu gp120, und ihre verwendungen |